Versant Capital Management, Inc Takeda Pharmaceutical CO LTD Transaction History
Versant Capital Management, Inc
- $750 Million
- Q4 2025
A detailed history of Versant Capital Management, Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Versant Capital Management, Inc holds 34,983 shares of TAK stock, worth $499,907. This represents 0.07% of its overall portfolio holdings.
Number of Shares
34,983
Previous 27,070
29.23%
Holding current value
$499,907
Previous $396,000
26.01%
% of portfolio
0.07%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding TAK
# of Institutions
384Shares Held
80.5MCall Options Held
1.67MPut Options Held
276K-
Capital Research Global Investors Los Angeles, CA13.4MShares$192 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$84.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.95MShares$70.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...